Flowserve heads into the back half of August with a notable divergence: short sellers are quietly exiting while options traders are making some of the most bullish bets seen in a year.
The options signal is the sharpest read in the data. Call demand has overwhelmed puts to a degree that is statistically extreme — the put/call ratio dropped to 0.11, a full two standard deviations below its 20-day average of 0.18. That reading is the lowest of the past 52 weeks. It marks a clean break from the prior month, when the PCR hovered consistently in the 0.19–0.21 range. Whatever drove that prior caution has faded fast.
Short positioning reinforces the same directional lean. Bears have been cutting exposure steadily — SI as a percentage of the free float fell to just under 6%, down almost 18% from a month ago when it peaked near 7.4%. The borrow market offers no friction to that retreat: availability is running at roughly 640%, meaning there are six shares available to lend for every one currently out on loan, among the loosest conditions of the past year. Cost to borrow is a negligible 0.49%, up modestly on the week but still well inside "easy" territory. Nothing in the lending market suggests any meaningful squeeze dynamic. The short score has drifted from 50 to 46.8 over the past two weeks — moving away from neutral in the direction of less bearish pressure.
The Street's stance is broadly constructive, though not without nuance. Following the Q2 results reported on July 30, RBC Capital raised its target to $94 and Stifel moved to the same level — both keeping positive ratings intact. The mean analyst target now sits at $89.10, roughly 11% above the current price of $80.56, suggesting the Street still sees room to run even after the stock's 11% gain over the past month. The bull case centres on margin expansion — adjusted operating margins hit 14.8% in the most recent quarter, up 370 basis points year-on-year — and strong aftermarket demand from North America and the Middle East, including double-digit nuclear and power bookings growth. Bears, by contrast, point to a narrowing organic sales guidance range of 1%–3%, which disappointed relative to prior expectations, and lingering uncertainty in oil and gas end markets. It is worth noting that TD Cowen downgraded to Hold in late June with a $70 target — that remains the outlier on the Street, sitting well below the pack, and FLS has since traded through that level and beyond.
One institutional move stands out. Fidelity International reported a fresh position of 4.16 million shares as of June 30 — a new entry into the top holders list — while Durable Capital Partners added 1.96 million shares in the same period. On the other side, D1 Capital trimmed nearly 906,000 shares. The net picture is of institutional interest rebuilding, not rotating out. Insider activity over the past 90 days has been modest but positive: two independent directors bought shares in May at prices around $65–$67, well below current levels. The net 90-day insider position is a small positive at just under $245,000 in value.
Earnings history adds a useful frame. The most recent print on July 30 triggered an 8.7% one-day move and a 12.4% five-day rally — a notably strong reaction by any measure. The next earnings date is October 30, which gives the current positioning dynamic roughly two months to play out. With the PCR at a 52-week low, SI retreating, and availability loose, positioning looks unambiguously bullish rather than cautious — the question for the weeks ahead is whether the fundamental delivery on bookings and margins keeps pace with what the options market is already pricing in.
See the live data behind this article on ORTEX.
Open FLS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
